Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Biomanufacturing Outlook

Industry optimism is on the rise for 2012.
Mar 7, 2012

Industry optimism is on the rise for 2012.

Biomanufacturing Outlook

Industry optimism is on the rise for 2012.
Feb 2, 2012

Industry optimism is on the rise for 2012.

Biosimilars' Technology Needs

Biosimilar manufacturers need better expression systems and analytical tools to compete.
Dec 7, 2011

Biosimilar manufacturers need better expression systems and analytical tools to compete.

Biosimilars' Technology Needs

Biosimilar manufacturers need better expression systems and analytical tools to compete.
Nov 2, 2011

Biosimilar manufacturers need better expression systems and analytical tools to compete.

Offshoring Biomanufacturing

China rises to the top as a destination for international outsourcing.
Sep 8, 2011

China rises to the top as a destination for international outsourcing.

Offshoring Biomanufacturing

China rises to the top as a destination for international outsourcing.
Aug 2, 2011

China rises to the top as a destination for international outsourcing.

Wanted: Better Upstream Bioprocessing Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jul 12, 2011

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Wanted: Better Upstream Bioprocessing Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jun 2, 2011

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Changes Underway for Biopharmaceutical Outsourcing

More crucial biomanufacturing operations are expected to be outsourced.
Mar 2, 2011

More crucial biomanufacturing operations are expected to be outsourced.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here